PH
Pharmena S.a.
PHR.WA · WSE
3.40 zł +1.49% (+0.05 zł)
1M +7.37%
Market Cap 37.3M zł
P/E Ratio -
Div. Yield -
ROE 32.58%
Piotroski F-Score Weak
3/9Valuation
21 /100
Expensive P/S 25.54x
P/B 4.57x
P/E N/A
Growth
100 /100
Growing Rev. growth 74.07%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 77.41%
Net margin 209.24%
Op. margin 228.54%
Quality
2 /100
Poor ROIC 39.50%
ROE 32.58%
ROA 32.03%
Debt
69 /100
Low Debt/Equity 0.04x
Current ratio 6.69x
Int. coverage -108.97x
Stability
20 /100
Unstable Beta 0.50x
Rev. volatility 1,753.44%
EPS volatility 1,196.84%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PHR.WA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Konrad Palka
Employees
7
Headquarters
Lódz